Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...
Recent clinical trials of Novo Nordisk’s blockbuster GLP-1 drug semaglutide for Alzheimer’s disease may have failed to show ...
Developed in partnership with agency Wieden+Kennedy Portland, Lilly’s Good Days officially launched on Sunday. The spot will air in the final slot before showings of Wicked: For Good and during the ...
Eli Lilly and Co. and Indiana University on Wednesday announced a new agreement that would see the Indianapolis-based ...
Indiana University and Eli Lilly are working together to expand clinical trials in the state. IU President Pamela Whitten and ...
Montgomery Advertiser on MSN
Eli Lilly to spend $6B on AL plant for next-gen drugs. What to know
Eli Lilly is investing $6B in a Huntsville, Ala., plant to make weight-loss and other medicines. Here’s what we know about ...
Macquarie Asset Management, an investment management company, released its “Macquarie Large Cap Growth Fund” investor letter for the second quarter of 2025. A copy of the letter can be downloaded here ...
Pfizer (PFE), and Johnson & Johnson (JNJ) secured spots on China's first innovative drug catalog for private insurance, ...
INDIANAPOLIS — Indiana University and pharmaceutical giant Eli Lilly have made official a five-year collaboration in which ...
It's Alzheimer's Awareness month and navigating cognitive health conversations can be difficult. Actress, Julianne Moore partnered with Eli Lilly for their 'Brain Health Matters' Campaign and told us ...
Eli Lilly is continuing its recent pattern of tying disease awareness-raising efforts to major pop cultural moments. The latest high-profile crossovers—which include a starry TV partnership and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback